SCHEMBL1090083

SCHEMBL1090083

COc1ccc(CN2CC(Nc3nccc(N4CCCCCC4)n3)C2)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.59
ACHE P22303 2/20 0.51
LMNA P02545 2/20 0.48
TSHR P16473 2/20 0.48
POLB P06746 1/20 0.48
ALOX15 P16050 1/20 0.48
CRHBP P24387 1/20 0.48
CRHR2 Q13324 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
ALK Q9UM73 1/20 0.46
HRH4 Q9H3N8 3/20 0.45
BACE1 P56817 1/20 0.43
EHMT2 Q96KQ7 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
FAAH O00519 1/20 0.42
SSTR5 P35346 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1088953 0.92 CXCR4 (0.56) CXCR4ACHEALKHRH4BACE1
SCHEMBL1090907 0.92 CXCR4 (0.56) CXCR4ACHEALKHRH4EHMT2
SCHEMBL1091199 0.91 CXCR4 (0.61) CXCR4ACHELMNATSHRBACE1
SCHEMBL1091081 0.90 CXCR4 (0.51) CXCR4ACHELMNATSHRPOLB
SCHEMBL1089498 0.90 CXCR4 (0.59) CXCR4ACHEPOLBALKHRH4
SCHEMBL1090761 0.87 CXCR4 (0.58) CXCR4ACHEALKHRH4BACE1
SCHEMBL1090222 0.87 CXCR4 (0.65) CXCR4ACHEALKHRH4BACE1
SCHEMBL1091510 0.85 CXCR4 (0.63) CXCR4ACHEALKHRH4BACE1
SCHEMBL1090277 0.85 CXCR4 (0.71) CXCR4ACHELMNATSHRBACE1
SCHEMBL1089797 0.85 CXCR4 (0.66) CXCR4ACHELMNATSHRHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885ACHE 4384/4885LMNA 3658/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885ACHE 4384/4885LMNA 3658/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885ACHE 4384/4885LMNA 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.